Crimson Publishers Publish With Us Reprints e-Books Video articles

Full Text

Advances in Complementary & Alternative medicine

Homeopathy for the Treatment of Transmissible Venereal Tumor (TVT) in a Mixed-Breed Female Dog

Ana Catarina Viana Valle1,2*, Marcelo Sibata2, Rosangela Vieira Andrade1 and Aloísio Carvalho3

1Catholic University/ Department of Genetics and Biotechnology, Brasilia, Brazil

2Doctor Izao Soares Institute/ Department oh Veterinary Homeopathy, Ribeirao Preto, Brazil

3Paulista University/ Department of Experimental Pathology, Sao Paulo, Brazil

*Corresponding author:Ana Catarina Viana Valle, Brasilia, DF, Brazil,

Submission: July 16, 2019;Published: July 19, 2019

DOI: 10.31031/ACAM.2019.05.000602

ISSN: 2637-7802
Volume5 Issue1


The diagnosis of canine transmissible venereal tumor (TVT) in based on clinical, cytological and/or histopathological examination. Vincristine sulfate is the conventional treatment of choice. Furthermore, homeopathy is also a therapeutic possibility by the use, for example, of Viscum album, which has been employed in the treatment of cancer. A 2-year-old mixed-breed female dog diagnosed with TVT was orally treated with Thuya occidentalis 6x10-12; topical application of T. occidentalis 9x10-18 in the lesion; and V. album subcutaneous applications in different dilution combinations. The tumor was reduced by about 90% during 150 days of treatment, and the patient had no longer bloody vaginal discharge. The complete remission was accomplished with a single vincristine application (0.025mgKg-1). No tumor was observed a week later, and the cytological examination confirmed the absence of tumor cells. No side effects were verified during the treatment period.

Keywords: Thuya occidentalis; Tumor remission; Viscum album


Transmissible venereal tumor (TVT) or Tumor de Sticker is a neoplasm of spontaneous occurrence more common in genital organs, not involving any infectious agents in its etiology [1]. TVT is a neoplasm characterized by the mechanical implantation of tumor cells in a healthy tissue by coitus [2] but can be transplanted to other sites by licking or direct contact [3].

This tumor affects dogs, with no sexual and racial predisposition, most commonly in free-living animals, especially in warmer times of the year [4]. The common clinical sign of that disease is bloody discharge from the affect sites due to increase in tumor size [5]. In general, the diagnosis is based on clinical, cytological, and/or histopathological examination. Chemotherapy, especially single agent of vincristine sulfate, is a treatment of choice for TVT. Currently, other therapies including radiotherapy, surgical excision, immunotherapy and autohemotherapy have also been demonstrated [2].

Homeopathy is also a therapeutic possibility, which can be established as a single treatment or associated with chemotherapy [6]. According to these authors, the association of homeopathic and chemotherapeutic medicines reduces the treatment time to which the animal is subjected, reducing the vincristine application frequency. Homeopathy was created by the German physician Samuel Hahnemann. It is based on the law of similars and may be indicated for treating several neoplasms. Thuya occidentalis, the most cited medicine, is wellknown for its therapeutic action in numerous pathologies [6]. In this context, Viscum album is gaining emphasis in oncological treatments due to the cytotoxic action of viscotoxins and lectins, some of its pharmacologically active compounds. The mechanism of action of these substances has not yet been elucidated, but it is known that lectins act in the cell membrane inducing apoptosis whereas viscotoxin induces rapid cell death by necrosis [7].

The combination of injectable V. album and vincristine has been reported to be effective as a therapy for TVT treatment in dogs, reducing the time of chemotherapic treatment and the leucopenia produced by the vincristine administration [8]. This study aimed to report the use of the homeopathic medicines V. album and T. occidentallis, in the TVT treatment of a mixed-breed female dog, for 150 days.

Material and Methods

A 2-year-old mixed-breed female dog, weighing 9.5Kg, was attended on November 2014 at Natural Pet - Integrative Veterinary Clinic (Brasilia, DF, Brazil). The animal had given birth in the previous two months and then presented persistent vaginal bleeding. In the first clinical evaluation, increased volume of the vaginal canal (4.9cm x 4.7cm) associated with bloody vaginal secretion was verified. The TVT diagnosis was confirmed by vaginal cytology, which showed a high cellularity of 2 cell population, round cells and neutrophils. The former cells were round and eccentric nucleus, granular chromatin, and distinct bluish cytoplasm with small vacuoles. Red blood cells, bacteria, and epithelial cells were also observed.

Hemogram analyses were normal and resulted in red blood cells: 6.3x106mm3; Hematocrit: 40%; Hemoglobin: 13.5g%; total proteins: 7.2g/dL; VCM: 63.4%; Leukocytes 15,200/mm3; Lymphocytes 18%; Platelets: 354,000mm3. Oral administration of T. occidentallis 1x10-12 solution, three drops, three times a day, and topical application of T. occidentallis 1x10-18 solution, three drops, in the lesion site, once-per-day, were initially prescribed. After seven days (Figure 1A), the V. album injectable therapy was started. The treatment consisted of one subcutaneous application (1ampoul - 1mL) of V. album solution, per day. V. album applications followed a predetermined sequence of different potencies, as described: day 1) 1x10-6+1x10-12; day 2) 1x10-18+1x10-24; day 3) 1x10-60+1x106; day 4) 1x10-12+1x10-18; day 5) 1x1024+1x10-60. This sequence was performed intermittently for 30 days. From the second month onwards, V. album applications were performed on alternate days, following the same administration sequence described above.


A reduction of the mass to 3.0cm x 2.3cm was observed at the end of the first treatment phase, which lasted 30 days (Figure 1B). From the second month onwards, V. album was applied on alternate days and, after 30 days, the tumor diameter was reduced to 2.0cm x 2.0cm. After 90 and 150 days of treatment, the mass measured 1.0cm x 0.9cm (Figure 1C) and 0.5cm x 0.4cm (Figure 1D), respectively. The Hemogram in June/2015 showed red blood cells: 6.8X106mm3; Hematocrit: 45%; Hemoglobin: 15g%; Total protein: 8g/dL; MCV: 66.1fl; Leukocytes 15,800/mm3; Lymphocytes 25%; Platelets: 265,000 mm3. Urinalysis in June/2015 showed cloudy aspect; color-yellow citrine; odor-sui generis; pH-6.0; density-1.050; ptn+(30mg/dL); light bacteriuria (coccus). At this time, a single vincristine application (0.025 mg Kg-1) was performed to complete remission of the tumor mass and completion of the treatment. Two months later after vincristine application Hemogram in October/2015, showed red blood cells: 7.5 X106 mm3; Hematocrit: 50%; Hemoglobin: 17.6g%; Total protein: 8g/dL; MCV: 66.7fl; Leukocytes: 14,000/mm3; Lymphocytes: 15%; Platelets: 271,000mm3. Biochemical analyzes showed Creatinine: 1.1mg/dL; ALT: 48.9UI/L.

Figure 1:Transmissible venereal tumor (TVT) reduction in a mixed-breed female dog as a response to Thuya occidentallis and Viscum album after 7(A), 30(B), 90(C), and 150(D) days after treatment beginning.

The clinical examination was performed one week later, and no tumor mass was observed in the vaginal canal of the dog. The absence of tumor cells was confirmed by cytological examination. The animal had overall good health, and side effects were not manifested during the treatment period.


TVT is the most common neoplasm that affects the external genitalia of dogs and one of the causes of higher demand for veterinary care. TVT incidence is high in Brazil due to the tropical climate and large number of stray and sexually active dogs [2]. Several therapies are proposed for the treatment of this disease, such as chemotherapy, radiotherapy, immunotherapy, surgical excision, homeopathy.

Chemotherapy is the treatment of choice for this disease, and vincristine sulfate is used as the single medication. However, chemotherapy side effects and the increased reports of patient resistance to vincristine therapy, have stimulated the search for new and useful substances against TVT [6]. According to this

author, studies have shown that the association of vincristine with ivermectin or homeopathic and herbal medicines, which promote immunostimulation, may reduce the application number of the chemotherapic and also its side effects.

In this study, the homeopathic medicines V. album, subcutaneously injected, and T. occidentallis, orally administered, reduced about 90% of the tumor during 150 days of treatment, with no manifestation of side effects. These results conform with those of Lefebvre et al. [8], who also observed no side effects in the patient when using injectable V. album to reduce tumor size.

The prescription of T. occidentallis was due to pathogenetic similarity (Vannier and Poirier, 1987), aiming at a complementary treatment. Manhoso, et al. [6] and Santos et al. [2] also reported satisfactory results when using T. occidentallis for TVT treatment. The significant reduction observed in the mass substantially minimized the use of vincristine. Therefore, only one application of this chemotherapeutic was required for complete resolution of the disease [9,10].


V. album and T. occidentalis proved to be important therapeutic tools for the treatment of canine TVT. T. occidentallis oral and topical administration associated with V. album injectable therapy significantly reduced the tumoral manifestation of the disease, with no side effects, such as leucopenia. The patient’s overall health was preserved, and the quality of life was improved. However, further studies are needed to fully understand how homeopathic medicines act in the treatment of this disease.


  1. Carvalho AC (2015) Antineoplastic activity of Viscum album (L) in experimental tumors: Critical review and experimental study in Ehrlich’s tumor. Doctoral thesis, University of São Paulo, Sao Paulo, Brazil, p. 72.
  2. Santos MP, Ladir EC, Moraes JC, Ferreira FA (2006) Use of homeopathy in the treatment of transmissible venereal tumor in a mixed-breed female dog-Case report. Veterinária Notícias 12(2): 138.
  3. Nelson RW (1992) CG internal medicine of small animals (2nd edn). Guanabara Koogan, Rio de Janeiro, Brazil.
  4. Santos MSP, Nagashima JC, Mountain FP (2011) Transmissible venereal tumor (TVT)-Review of literature. Semiannual Periodicals Electronic Science Review of Veterinary Medicine 10: 16.
  5. Vural SA, Haziroglu R, Vural MR, Polat IM, Tunc AS (2018) Detection of progressive and regressive phase and LINE-1 retrotransposon in transfected dogs with transmissible venereal tumor during chemotherapy. J Vet Sci 19(5): 620-626.
  6. Manhoso FFR, Pichini E, Santos PCG, Silva GI, Lombardi E, et al. (1997) Homeopathy and chemotherapy use in contagious venereal tumour treatment and its hematological aspects. Pesq Homeop 12(2): 50-64.
  7. Werthmann PG, Huber R, Kienle GS (2018) Durable clinical remission of a skull metastasis under intralesional Viscum album extract therapy: Case report. Head Neck 40(7): 77-81.
  8. Lefebvre GNF, Bonamin LB, Oliveira CM (2007) Treatment of transmissible venereal tumor (TVT) using Viscum album in combination with chemotherapy. Rev Clin Vet 70: 78-86.
  9. Lopes DF (2008) Viscum album citotoxicity in Caco 2 cells (in vitro) analyzed by Dispersive Raman Spectroscopy. Int J High Dilution Res 7(23): 7778.
  10. Vannier L, Poirier J (1987) Homeopathic medical matter treaty. São Paulo, Brazil, p. 448.

© 2019 Ana Catarina Viana Valle. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially.

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137